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OBJECTIVES: To investigate and discuss current fluid and blood products stocked in small animal 
 practices in the UK.
METHODS: An online survey was circulated to small animal veterinary practices across the UK. The 
survey included questions regarding the level of hospital care provided, the type of fluid and blood 
component products stocked, the most frequently restocked products, and the available options in the 
event that blood products were required but not stocked.
RESULTS: There were 423 responses including 27 duplicates. The remaining 396 respondents 
 represented a spectrum of practices including 19 referral practices. Crystalloids were stocked in all 
practices. Lactated Ringer’s solution was the most frequently re-stocked product in 355 of 396 (90%) 
of practices. Where synthetic colloids were stocked, gelatin-based colloids (155/178 [87%]) were 
stocked in preference to hydroxyethyl starches (23/178 [13%]). Blood products were stocked by 81 
of 396 (20%) of practices. If a blood product was required but not stocked, 31% of practices would 
use a pet blood banking service, 28% would use their own blood donors, and 21% would refer.
CLINICAL SIGNIFICANCE: This study provides an insight into the fluid and blood products stocked and used 
by a selection of veterinary practices within the UK and serves as a baseline for ongoing research and 
decision-making in both veterinary practice and industry.
INTRODUCTION
Fluid therapy has been an integral part of both human and vet-
erinary medicine for decades, particularly in management of 
critically ill patients. Historically, 0.9% saline has been the most 
widely used crystalloid in people, however, in more recent years, 
many varieties of fluids have been developed with a range of dif-
ferent indications and there has been a shift towards use of bal-
anced isotonic crystalloids. Balanced isotonic crystalloids have 
an electrolyte content closer to that of extra-cellular fluid and, 
when given intravenously, may have fewer adverse effects on acid-
base balance than 0.9% saline (Drobatz & Cole! 2008, Semler 
et al.!2018, Semler & Kellum!2019). With such an array of prod-
ucts available and such variation in practice type within veterinary 
medicine, fluid product provision can be complicated and most 
current literature does not comply with recommended evidence 
standards, making an evidence base difficult to establish (Muir 
et al.!2017).
Fluid therapy products available in veterinary medicine can 
be separated into two broad categories, crystalloid and colloid 
solutions. Crystalloids are aqueous solutions of small (<5!kDa) 
electrolytes and other soluble components, and are further classi-
fied as hypotonic, isotonic or hypertonic solutions, based on their 
tonicity relative to plasma. Their primary use is in replenishment 
of fluid deficits and catering for ongoing losses in the interstitial 
and intravascular spaces of dehydrated and hypovolaemic patients, 
respectively. Maintenance fluid products containing less sodium 
such as 0.45% NaCl with 2.5% dextrose are recommended for 
patients that are not eating or drinking, but do not have volume 
deficits or ongoing losses (Mazzaferro &  Powell!2013).
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Colloidal solutions, however, are relatively more expen-
sive, can be allergenic and have known effects on coagulation 
and renal function in human and veterinary patients alike 
(Chan! 2008, Mutter et al.! 2013, Boyd et al.! 2018). Nonethe-
less, there are indications in veterinary practice for the use of 
colloids. The high molecular weight of the dissolved colloid mol-
ecules contributes to oncotic pressure to retain water within the 
intravascular space (Pachtinger & Drobatz!2008). Colloids may 
be considered advantageous in the treatment of recurrent hypo-
volaemia and/or hypoproteinemia, particularly if the glycocalyx 
integrity is still preserved (Milford & Reade!2019). Colloids can 
be divided into natural products, such as plasma or albumin, 
and synthetic products including gelatins, hydroxyethyl starches 
(HES) and dextrans.
Progressions in the field of blood component therapy have 
enabled provision of safer, storable and more tailored products 
than whole blood (Davidow!2013). Increased availability of these 
blood products allows clinicians to make more individualised 
therapy plans for patients.
An increasing number of veterinary recommendations 
and guidelines are being generated to help practitioners make 
appropriate choices of fluid products (Shafford et al.! 2013, 
Byers!2017). The same is true for blood products (Barfield & 
Adamantos!2011, Davidow!2013). While these often exemplify 
‘gold-standard’ choices, they do not always reflect what is acces-
sible or stocked in all practice settings. Much of the current veter-
inary literature regarding fluid therapy and blood products does 
not specifically focus on a UK population, and recommendations 
often involve products that are more readily available in North 
America. This study aims to investigate and discuss current fluid 
and blood products actually stocked and used in small animal 
practices in the UK.
MATERIALS AND METHODS
Ethical approval was obtained by the Social Sciences Research 
Ethical Review Board (SSRERB) at the author’s institution. A 
survey was created on an online professional survey program 
(SurveyMonkey Professional Online Surveying Program [www. 
surveymonkey.com]) and was distributed to small animal prac-
tices across the UK via an email invitation sent between 28th Feb-
ruary 2019-2nd March 2019. The email addresses were obtained 
from the RCVS website after using the search system to select 
for practices which treated both cats and dogs as a minimum. 
The survey was further circulated via social media. Participation 
was entirely voluntary, and the survey remained open until 26th 
March 2019. A £50 voucher prize draw was used as an incentive 
for completion of the survey.
The survey was designed to take less than 3 minutes to com-
plete and could be answered by any member of the veterinary 
practice to help maximise response rates. Respondents were 
asked five questions as shown in Appendix 1; one pertaining 
to each of the following: the type of practice, all types of fluid 
products currently stocked, the fluid type that is most frequently 
restocked, the types of blood component therapy stocked (if 
any) and the procedure in the event that a blood component is 
required but not stocked. There was an option to provide a free 
text answer for further details or products stocked at the end of 
each question.
All free-text answers were reviewed and where necessary, 
combined with the primary dataset. Respondents categorised 
themselves as one of the following according to the amount of 
hospital care provided: branch/standalone practice (consults 
only), branch/standalone practice (+ routine procedures/imag-
ing), hospital without onsite overnight care, hospital with onsite 
overnight care, 24-hour hospital, referral hospital, and 24-hour 
referral hospital. For subsequent analysis, these were grouped into 
first opinion (consults only, consults ± routine procedures, hospi-
tal ± overnight care and 24-hour hospitals) and referral (referral 
hospitals and 24-hour referral hospital) practice.
Statistical analysis
Data were compiled into commercially available software (Micro-
soft Office 2010. Microsoft Excel (version 14). Microsoft Corpo-
ration, 2010. Redmond, WA) and percentages were calculated 
from frequency data.
RESULTS
The online survey was emailed to 2994 small animal veterinary 
practices and 423 responses were received. The survey had a 
completion rate of 99.8% (422/423); a single respondent did 
not complete the final question. After incomplete or duplicate 
responses from individual practices were removed, the total num-
ber of valid responses was 396 of 423 (93.6%). Duplicates were 
identical in 26 of 27 (96.3%) responses. Of these responses, the 
majority were from first opinion practices performing routine 
procedures (256/396 [64.6%]). The remaining proportions are 
displayed in Fig!1.
Fluid therapy products
A summary of the most frequently stocked crystalloid products 
stocked by practices can be seen in Fig!2. Every practice stocked 
lactated Ringer’s solution (LRS) (396/396 [100.0%]) and the 
majority of practices also stocked 0.9% NaCl (saline) (386/396 
[97.5%]). Plasmalyte-148 was stocked by 6 of 396 (1.5%), Nor-
mosol R by 1 of 396 (0.3%), Plasmalyte-56 by 3 of 396 (0.8%) 
and Normosol M by 0 of 396 (0.0%) practices. Sterile water for 
injection was stocked in 346 of 396 practices (87.4%).
The most frequently stocked hypotonic crystalloid solution 
was 0.18% NaCl +4% dextrose which was present in 111 of /396 
(28.0%) of practices. Mannitol was the most frequently stocked 
hyperosmolar agent (169/396 [42.7%]), followed by hypertonic 
saline (100/396 [25.3%]). Neither mannitol nor hypertonic 
saline were stocked in 194 of 396 (49.0%) practices.
Synthetic colloids (SCs) were reportedly stocked in 45% 
practices (178/396), of which Gelofusine (155/178 [87.1%]) 
was the most popular, followed by Voluven (23/178 [13%]). 
Eleven practices (11/178 [6.2%]) kept more than one type of 
SC in stock, and one of these products was always Gelofusine. 
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When asked to select which fluid product was most com-
monly used/restocked in their veterinary practice, the majority 
of respondents selected LRS (355/396 [89.7%]). 0.9% sodium 
chloride (saline) was the second most commonly replaced fluid 
(38/396 [9.6%]) and the remaining three respondents answered 
with 0.18% NaCl with 4% dextrose.
Blood products
A summary of the blood products stocked by all practices can 
be seen in Fig 3. Blood products were stocked by 20.0% of 
practices (81/396). Canine fresh frozen plasma was the most 
frequently stocked blood product (67/396 [16.9%]), followed 
by canine stored frozen plasma (38/396 [9.6%]) and canine 
packed red blood cells (27/396 [6.8%]). Feline packed red blood 
cells and feline fresh frozen or stored plasma were stocked by 
6 of 396 (1.5%) and 4 of 396 (1.0%) practices, respectively. 
Human serum albumin (HSA) was stocked by 8 of 396 (2.0%) 
and canine serum albumin (CSA) was stocked by one practice. 
Cryoprecipitate was stocked in 2 of 396 practices (0.5%) and no 
practices stocked platelet products. Haemoglobin-based oxygen 
carrying solutions were reported to be stocked in 6 of 396 prac-
tices (1.5%).
The final question asked what practices would usually do in 
the event that a patient required a blood product but no appro-
priate products were stocked. The total number of responses for 
this question was 363. Using a pet blood bank was the single 
most popular choice (113/363 [31.1%]), followed by using 
blood donors from their records (104/363 [28.6%]). Twenty-
one percent of practices would refer their patients (77/363) and a 
further 60 of 363 practices (16.5%) transferred their patients to 
a main branch or nearby hospital. Sixteen practices gave free-text 
answers and commented that they would use combinations of 
the above on a case-by-case basis.
FIG 1. (A) The number of practice types that completed the survey. (B) Distribution of responding practices across the UK
FIG 2. (A) Summary of crystalloid products stocked by practices. 
Practices have been grouped into first opinion and referral practice. NaCl, 
sodium chloride; NaHCO3, sodium bicarbonate. (B) Summary of blood 
products stocked by practices. Practices have been grouped into first 
opinion and referral practice. RBCs red blood cells
No clinic stocked more than two SCs. Dextrans and Volulyte 
were stocked in 2 of 396 (0.5%) and 2 of 396 (0.5%) practices, 
respectively.
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DISCUSSION
Crystalloids
In recent years, research has raised concerns over the safety of 
saline compared to more physiologically balanced crystalloid 
solutions, such as LRS (Semler & Kellum!2019). These studies 
include recent clinical trials in people which have demonstrated 
higher rates of adverse kidney events and death in patients man-
aged with saline (cf. balanced crystalloids) (Self et al.! 2018, 
Semler! 2018). Fluids with higher chloride content, such as 
0.9% NaCl, have been associated with increased risk of acid-
base imbalances and hyperchloraemia when compared to bal-
anced isotonic crystalloids (Raghunathan et al.!2014, Krajewski 
et al.!2015). Although these evidence bases in favour of balanced 
crystalloids are growing, there are studies with neutral results 
(Young et al.!2015, Weiss et al.!2017).
In the majority of critically-ill hospitalised patients, it is 
likely that balanced, more physiological crystalloids with alka-
linising effects carry a slight advantage (Drobatz & Cole!2008, 
Semler!2018). In this study, 89.7% of practices used LRS most 
frequently, compared to 9.6% favouring saline, in concordance 
with a recent veterinary study (Hopper et al.!2018).
Alongside LRS, Plasmalyte-148 (PL-148) and Normosol-R 
are also frequently named in veterinary fluid guidelines as appro-
priate balanced crystalloid solutions to use as replacement fluids 
(Mazzaferro & Powell!2013). Unlike LRS, which contains lac-
tate as a bicarbonate precursor, both PL-148 and Normosol-R 
contain acetate and gluconate instead, with a small amount of 
magnesium instead of calcium. Their osmolality is slightly closer 
to that of plasma (cf. LRS) and are also considered balanced; they 
may be recommended in metabolic acidosis due to a slightly alka-
linising effect (Weinberg et al.!2016). However, PL-148 retails at 
more than 10 times the price of LRS (£44.20 (PL-148) versus 
£2.80 (LRS) for 500 mL, excluding VAT, from Henry Schein), 
and Normosol products are not known to be sold by any of the 
main UK veterinary suppliers. These factors, combined with a 
lack of familiarity, are likely contributary to why these products 
have not become more mainstream in the UK, being stocked in 
only 0.8% of practices.
Hypotonic crystalloid solutions were stocked infrequently, 
particularly those that are primarily recommended as mainte-
nance fluids such as 0.45% NaCl with 2.5% dextrose, Plasma-
lyte-56 and Normosol-M (Mazzaferro & Powell!2013). The most 
frequently stocked hypotonic solution in this study was 0.18% 
NaCl +4% dextrose which is marketed as a maintenance crys-
talloid following replenishment of fluid deficits. Maintenance 
crystalloids typically contain less sodium and more potassium 
than replacement fluids. The second most popular hypotonic 
solution, dextrose 5% in water (D5W), is not recommended as 
a maintenance fluid alone due to risks of in-hospital hypona-
traemia (Wang et al.!2014), but it can be combined with LRS 
or saline to make appropriate strength solutions. D5W is most 
commonly used for delivery of free water in cases of severe hyper-
natraemia (Mazzaferro & Powell! 2013). D5W was stocked by 
9.3% of practices, however, those practices which did not stock 
D5W may make it up themselves when required, using intrave-
nous glucose and sterile water for injection, which was reported 
to be stocked in 87.4% of practices.
Twenty-five percent of the responding veterinary practices 
stocked hypertonic saline, a crystalloid often utilised in the initial 
management of acute hypovolaemic shock (in patients with nor-
mal hydration status), particularly in larger dogs (Mazzaferro & 
Powell!2013, Shafford et al.!2013). HTS is also a first-line treat-
ment option for reduction of intracranial pressure in the man-
agement of traumatic brain injuries (TBI), inflammatory CNS 
disease or intracranial neoplasia (Mangat et al.! 2015, Carney 
et al.!2017). The other common treatment option in these cases 
is mannitol (Yozova et al.!2017a), stocked by 43.0% of practices. 
It remains unclear which of these two are superior in the treat-
ment of TBI (Boone et al.!2015), however, it would make sense 
that in patients with both TBI and hypovolaemia, HTS may be 
more appropriate when hypernatraemia is not an immediate con-
cern. In the current study, 194 of the responding practices report-
edly stocked neither product, including seven 24-hour hospitals 
and one 24-hour referral hospital.
Colloids
The lower stocking frequency of colloids is likely attributable to 
costs, infrequent indication for their use, familiarity, concerns 
regarding safety and availability. Overall, Gelofusine proved to 
be the most frequently stocked SC, followed by HES products 
(Voluven/Volulyte). The reported stocking of dextrans was sur-
prising as they are the least favoured SC in people and have been 
associated with negative effects on haemostasis, and risks of ana-
phylaxis and renal failure (Ertmer et al.! 2009). Consequently, 
they are no longer sold in several countries, including the USA 
and it is unclear whether they are still available in the UK.
The popularity of gelatin-based colloids compared to 
HES is contrary to trends identified in similar survey studies 
(Yozova et al.! 2017b, Hopper et al.! 2018). One of these stud-
ies reported that 85% of the respondents selected HES as their 
most commonly used SC (c.f. only 4% selecting gelatins) (Yozova 
et al.!2017b). North America was overrepresented in these stud-
ies therefore the differences may be regional. Alternatively, this 
may be a reflection of the declining availability and popularity 
of HES products due to European Union restrictions on their 
use due to concern over their safety profile. Multiple human 
trials have documented increased risk of acute kidney injury, 
requirement for renal replacement therapy and risk of death 
when HES are used (Myburgh et al.! 2012) particularly in the 
critically ill (Zarychanski et al.! 2013). Veterinary retrospective 
studies have found conflicting results in patients receiving HES 
products as they have been reported to be safe in non-azotaemic 
patients (Yozova et al.!2016, Sigrist et al.!2017) but have been 
associated with an adverse outcome including death or acute 
kidney injury (Hayes et al.!2016). This latter study investigated 
an older HES product (pentastarch) while newer generations of 
tetrastarches, such as Voluven and Volulyte, are purported to be 
more safe due to faster degradation and less tissue accumulation 
(Brooks et al.!2016, Hayes et al.!2016). Recent evidence has also 
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raised concern over gelatin-based colloids due to elevations in 
urinary biomarkers of AKI when compared to other SCs (Boyd 
et al.!2019).
At this stage, there is insufficient evidence in veterinary spe-
cies to draw definitive conclusions regarding safety of HES 
products and further prospective studies are required. Currently, 
HES products are still available to purchase in the UK, albeit at 
approximately four times the price of gelatins.(£7.15/£7.90 per 
500 mL Gelofusine/Geloplasma 4% cf. £30.32 per 500 mL Volu-
ven 6%, excluding VAT, from Henry Schein)
Blood products
Canine blood products
Canine FFP was the most frequently stocked blood product 
although its use was not explored in this study. A hospital-based 
study indicated that FFP was primarily used in the management 
of coagulopathies in animals (Snow et al.!2010).
HSA was more popular than CSA, which was reportedly 
stocked by one practice. Infrequent stocking may also be related 
to the relatively high cost of albumin products and risk of immu-
nological reactions, which is often considered to be prohibitive 
to their use and would parallel the declining use of albumin in 
people (Yano et al.!2019).
Haemoglobin-based oxygen carrying solutions were rarely 
reported, with six respondents reporting to stock them. It is sur-
prising to hear of practices stocking these products as Oxyglobin® 
is no longer available. In principle, their lack of a ‘blood type’, 
lower disease transmission risk and long shelf-life make them an 
appealing alternative to pRBCs (Zambelli & Leisewitz!2009). In 
practice, however, known adverse effects and their short plasma 
half-life (12-20 hours) has limited their applications. An alterna-
tive, investigational haemoglobin-based oxygen carrying solution 
is occasionally available to people in the USA under an expanded 
access program, but not in Europe (Hemoglobin Oxygen Thera-
peutics LLC|!2020) while polynitroxylated-pegylated haemoglo-
bin also remains under active research (Cao et al.!2017).
Feline blood products
Only 2.5% of practices, all referral hospitals, stocked feline-spe-
cific products (pRBC or plasma). This is likely due to difficulties 
in the collection and storage of blood products in cats.
Blood product acquisition
Thirty-one percent of practices reported use of a blood bank in 
the event that the appropriate product was not stocked. This 
was a more popular choice than using a blood donor from their 
records. Now that large-scale blood product storage is possible 
due to the amendment to the 2002 Veterinary Medicine Regula-
tions Act in 2007 (Parliament of the United Kingdom! 2007), 
Pet Blood Bank UK and BSA Animal Blood Bank offer quick 
delivery of products in the event of an emergency. Prior to the 
2007 Veterinary Medicines Regulation Act, veterinarians were 
only authorised to collect blood for immediate or anticipated use 
under the Animal (Scientific Procedures) Act (Parliament of the 
United Kingdom!1986).
Study limitations
The survey was purposefully designed to be completed quickly, 
by anyone within the veterinary practice that was willing. This 
maximised the response rate but may have resulted in inaccura-
cies as responses may have been dependant on recall. We con-
tacted 2994 practices, however, only received responses from 396 
individual practices; an overall low response rate. Although Fig.!1 
shows that our respondents were, geographically, relatively well-
distributed, and we had a variety of practice types included, we 
cannot guarantee that our included practices are representative of 
all practices within the UK. Respondents were also asked to self-
categorise their practice, rather than using a practice standards 
scheme. This was intentional in order to maximise responses 
but may have resulted in inaccuracies. Several practices reported 
stocking of products such as dextrans and HBOCS which was 
surprising given recent difficulty in acquisition. While stocking 
of these products was not clarified, the authors speculate that 
this could have been reported in error or was not representa-
tive of use. Despite the above limitations, it can be reasonably 
assumed that the products described would correspond well to 
what is used by the practice. Finally, as with any survey, there 
is always a degree of error due to misinterpretation of questions. 
In an attempt to mitigate these errors, duplicate responses were 
compared and documented to be identical in all but one of 27 
duplicates.
In conclusions, crystalloids, namely balanced isotonic solu-
tions, are a mainstay in UK small animal veterinary practices. 
Colloid usage appears less frequent and gelatin-based products 
are more routinely stocked than HES. Keeping blood products in 
stock is not commonplace and blood products are often accessed 
from pet blood banking services. An awareness of the prod-
ucts that are stocked by small animal practices is imperative in 
constructing applicable evidence-based guidelines and teaching 
resources. Further research investigating the decision-making, 
indications, dosages, and benefits of fluid and blood products are 
required to generate evidence-based guidelines.
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